CorrlensCorrlens
Correlate

Correlation Analysis

Broadcom Inc. Common Stock vs Vertex Pharmaceuticals Inc

AVGO vs VRTX

+0.725

Strong positive

When one moves up, the other tends to follow.

AVGO logo

Broadcom Inc. Common Stock

AVGO

Broadcom is one of the largest semiconductor companies in the world and has also expanded into infrastructure software. Its semiconductors primarily serve computing and networking, with custom AI accelerators now accounting for the bulk of the business. It is primarily a fabless designer, but holds some manufacturing in-house, such as for its best-of-breed film bulk acoustic resonator filters that sell into the Apple iPhone. In software, it sells virtualization, infrastructure, and security software to large enterprises, financial institutions, and governments. Broadcom is the product of consolidation. Its businesses are an amalgamation of former companies like legacy Broadcom and Avago Technologies in chips, as well as VMware, Brocade, CA Technologies, and Symantec in software.

Market cap 1.5T

VRTX logo

Vertex Pharmaceuticals Inc

VRTX

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Market cap 110.5B · 6,400 employees

Apr 9, 2021 — Apr 7, 2026Daily1,254 observationsStockStockTechnologyHealthcare

Time Series

Rebased to 100

Green: AVGOGray: VRTX36 of 1,254 points (sampled)

Who Moves First

VRTX leads AVGO by 6 days

VRTX tends to move before AVGO.

Best correlation after shifting: +0.727 (13 shifts scanned)

Do They Crash Together?

Correlation by Market Regime

How these series behave when markets are rising, falling, or diverging. A correlation that holds in drawdowns is very different from one that only works in rallies.

Both Rising

+0.013

14 periods · Return correlation when both series rose

Both Falling

N/A

4 periods · Return correlation when both series fell

Diverging

-0.684

17 periods · Return correlation when series moved apart

R-Squared

52.6%

Share of variance in one series explained by the other.

Trend Agreement

56.4%

How often both series moved in the same direction period-to-period.

Overlap Quality

1,254

Deep shared window — 1,254 usable pairs.

Significance

p < 0.001

95% CI: [0.698, 0.750]

Scatter

XY Regression

20100200300400403161.2200250300350400450500512.3Broadcom Inc. Common StockVertex Pharmaceuticals IncData pointsFit (r = 0.725)

Pipeline

Data quality details

Pipeline Summary

1,254 paired observations survived the daily window.

Raw input

1,254

1,254

Normalized

1,254

1,254

Prepared

1,254

1,254

Aligned

1,254

1,254

Invalid removed

0

A: 0 / B: 0

Duplicates removed

0

A: 0 / B: 0

Alignment drops

0

A: 0 / B: 0

Series A

AVGO logo

Broadcom Inc. Common Stock

AVGO

Market cap 1.5T

Stock · 1,254 raw → 1,254 prepared

Series B

VRTX logo

Vertex Pharmaceuticals Inc

VRTX

Market cap 110.5B · 6,400 employees

Stock · 1,254 raw → 1,254 prepared

Sign agreement

100.0%

How often both values share the same sign.

Zero crossings

10

Estimated crossover points between normalized spreads.

Slope

0.7158

Linear regression slope.

Intercept

257.5152

Linear regression intercept.

Related Extremes

Highest and Lowest Correlated

Saved 3 hours ago · ID: stock-avgo-vs-stock-vrtx-daily-20260408-nngij1